The presence of bone metastases or axillary lymphadenopathy (N1) at the time of breast cancer diagnosis and the need for more than 1 course of chemotherapy were associated with a significantly poorer prognosis
The presence of bone metastases or axillary lymphadenopathy(N1) at the time of breast cancer diagnosisand the need for more than 1 course ofchemotherapy were associated with a significantlypoorer prognosis